# EDGAR Filing Document

**Accession Number:** 0000817720
**File Stem:** 0000817720-25-000115
**Filing Date:** 2025-11
**Character Count:** 121055
**Document Hash:** 0c41edc92c209eb44e1d342fca33a415
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000817720-25-000115.hdr.sgml**: 20251106

**ACCESSION NUMBER**: 0000817720-25-000115

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 94

**CONFORMED PERIOD OF REPORT**: 20250927

**FILED AS OF DATE**: 20251106

**DATE AS OF CHANGE**: 20251106

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SYNAPTICS Inc
- **CENTRAL INDEX KEY:** 0000817720
- **STANDARD INDUSTRIAL CLASSIFICATION:** SEMICONDUCTORS & RELATED DEVICES [3674]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 770118518
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0626

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-49602
- **FILM NUMBER:** 251458936

**BUSINESS ADDRESS:**
- **STREET 1:** 1109 MCKAY DRIVE
- **CITY:** SAN JOSE
- **STATE:** CA
- **ZIP:** 95131-1706
- **BUSINESS PHONE:** 408-904-1100

**MAIL ADDRESS:**
- **STREET 1:** 1109 MCKAY DRIVE
- **CITY:** SAN JOSE
- **STATE:** CA
- **ZIP:** 95131-1706

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SYNAPTICS INC
- **DATE OF NAME CHANGE:** 20010216

?xml version='1.0' encoding='ASCII'? syna-20250927

<u>[**Table of Contents**](#i5f09aefb843a4923977469c244fdfb01_7)</u>

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION** 

**WASHINGTON, D.C. 20549** 

______________________________________________________________________________________________________

**FORM 10-Q** 

______________________________________________________________________________________________________

**☒** **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the quarterly period ended September 27, 2025**

**☐** **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the transition period from&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; .**

**Commission file number 000-49602**

______________________________________________________________________________________________________

**SYNAPTICS INCORPORATED**

**(Exact name of registrant as specified in its charter)**

______________________________________________________________________________________________________

---

| | |
|:---|:---|
| **Delaware** | **77-0118518** |
| **(State or other jurisdiction of**<br>**incorporation or organization)** | **(I.R.S. Employer**<br>**Identification No.)** |

---

**1109 McKay Drive**

**San Jose, California 95131** 

**(Address of principal executive offices) (Zip code)** 

**(408) 904-1100** 

**(Registrant's telephone number, including area code)** 

______________________________________________________________________________________________________

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| <u>Title of each class</u> | <u>Trading Symbol(s)</u> | <u>Name of each exchange on which registered</u> |
| Common Stock, par value $.001 per share | SYNA | The Nasdaq Global Select Market |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☒ | Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
| | | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of October 30, 2025, the Company had 38,990,073 shares of Common Stock outstanding.

------

<u>[**Table of Contents**](#i5f09aefb843a4923977469c244fdfb01_7)</u>

**SYNAPTICS INCORPORATED** 

**QUARTERLY REPORT ON FORM 10-Q** 

**FOR THE QUARTER ENDED SEPTEMBER 27, 2025** 

**TABLE OF CONTENTS** 

---

| | | |
|:---|:---|:---|
| | | **Page** |
| <u>[Part I. Financial Information](#i5f09aefb843a4923977469c244fdfb01_10)</u> | <u>[Part I. Financial Information](#i5f09aefb843a4923977469c244fdfb01_10)</u> |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Item 1.](#i5f09aefb843a4923977469c244fdfb01_13) | <u>[Condensed Consolidated Financial Statements (Unaudited):](#i5f09aefb843a4923977469c244fdfb01_13)</u> |  |
|  | <u>[Condensed Consolidated Balance Sheets—](#i5f09aefb843a4923977469c244fdfb01_16)September 27, 2025[and](#i5f09aefb843a4923977469c244fdfb01_16)June 28, 2025</u> | [3](#i5f09aefb843a4923977469c244fdfb01_16) |
|  | <u>[Condensed Consolidated Statement](#i5f09aefb843a4923977469c244fdfb01_19)[s](#i5f09aefb843a4923977469c244fdfb01_19)[of](#i5f09aefb843a4923977469c244fdfb01_19)[Operations](#i5f09aefb843a4923977469c244fdfb01_19)[—](#i5f09aefb843a4923977469c244fdfb01_19)[Three Months Ended](#i5f09aefb843a4923977469c244fdfb01_19)September 27, 2025and September 28, 2024</u>  | [4](#i5f09aefb843a4923977469c244fdfb01_19) |
|  | <u>[Condensed Consolidated Statements of Stockholders' Equity—](#i5f09aefb843a4923977469c244fdfb01_25)[Three](#i5f09aefb843a4923977469c244fdfb01_19)[Months Ended](#i5f09aefb843a4923977469c244fdfb01_19)September 27, 2025and September 28, 2024</u>  | [5](#i5f09aefb843a4923977469c244fdfb01_25) |
|  | <u>[Condensed Consolidated Statements of Cash Flows—](#i5f09aefb843a4923977469c244fdfb01_28)Three [Months Ended](#i5f09aefb843a4923977469c244fdfb01_19)</u> <u>September 27, 2025[and](#i5f09aefb843a4923977469c244fdfb01_19)</u> <u>September 28, 2024</u>  | [7](#i5f09aefb843a4923977469c244fdfb01_28) |
|  | <u>[Notes to Condensed Consolidated Financial Statements](#i5f09aefb843a4923977469c244fdfb01_31)</u> | [8](#i5f09aefb843a4923977469c244fdfb01_31) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Item 2.](#i5f09aefb843a4923977469c244fdfb01_85) | <u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#i5f09aefb843a4923977469c244fdfb01_85)</u> | [26](#i5f09aefb843a4923977469c244fdfb01_85) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Item 3.](#i5f09aefb843a4923977469c244fdfb01_109) | <u>[Quantitative and Qualitative Disclosures About Market Risk](#i5f09aefb843a4923977469c244fdfb01_109)</u> | [32](#i5f09aefb843a4923977469c244fdfb01_109) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Item 4.](#i5f09aefb843a4923977469c244fdfb01_112) | <u>[Controls and Procedures](#i5f09aefb843a4923977469c244fdfb01_112)</u> | [32](#i5f09aefb843a4923977469c244fdfb01_112) |
| <u>[Part II. Other Information](#i5f09aefb843a4923977469c244fdfb01_115)</u> | <u>[Part II. Other Information](#i5f09aefb843a4923977469c244fdfb01_115)</u> |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Item 1.](#i5f09aefb843a4923977469c244fdfb01_118) | <u>[Legal Proceedings](#i5f09aefb843a4923977469c244fdfb01_118)</u> | [33](#i5f09aefb843a4923977469c244fdfb01_118) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Item 1A.](#i5f09aefb843a4923977469c244fdfb01_121) | <u>[Risk Factors](#i5f09aefb843a4923977469c244fdfb01_121)</u> | [33](#i5f09aefb843a4923977469c244fdfb01_121) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Item 2.](#i5f09aefb843a4923977469c244fdfb01_124) | <u>[Unregistered Sales of Equity Securities and Use of Proceeds](#i5f09aefb843a4923977469c244fdfb01_124)</u> | [34](#i5f09aefb843a4923977469c244fdfb01_124) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Item 3.](#i5f09aefb843a4923977469c244fdfb01_127) | <u>[Defaults Upon Senior Securities](#i5f09aefb843a4923977469c244fdfb01_127)</u> | [34](#i5f09aefb843a4923977469c244fdfb01_127) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Item 5.](#i5f09aefb843a4923977469c244fdfb01_130) | <u>[Other Information](#i5f09aefb843a4923977469c244fdfb01_130)</u> | [34](#i5f09aefb843a4923977469c244fdfb01_130) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Item 6.](#i5f09aefb843a4923977469c244fdfb01_136) | <u>[Exhibits](#i5f09aefb843a4923977469c244fdfb01_136)</u> | [36](#i5f09aefb843a4923977469c244fdfb01_136) |
| <u>[Signatures](#i5f09aefb843a4923977469c244fdfb01_139)</u> | <u>[Signatures](#i5f09aefb843a4923977469c244fdfb01_139)</u> | [37](#i5f09aefb843a4923977469c244fdfb01_139) |

---

------

<u>[**Table of Contents**](#i5f09aefb843a4923977469c244fdfb01_7)</u>

**PART I—FINANCIAL INFORMATION**

**ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)**

**SYNAPTICS INCORPORATED AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED BALANCE SHEETS**

(in millions, except par value and share amounts)

(unaudited)

---

| | | |
|:---|:---|:---|
| | **September 2025** | **June 2025** |
| **ASSETS** | | |
| Current Assets: |  |  |
| &nbsp;&nbsp;Cash and cash equivalents | $459.9 | $391.5 |
| &nbsp;&nbsp;Short-term investments |  | 61.0 |
| &nbsp;&nbsp;Accounts receivable, net | 119.5 | 130.3 |
| &nbsp;&nbsp;Inventories | 143.1 | 139.5 |
| &nbsp;&nbsp;Prepaid expenses and other current assets | 26.5 | 29.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 749.0 | 751.9 |
| Property and equipment, net | 77.4 | 72.1 |
| Goodwill | 872.3 | 872.3 |
| Acquired intangible assets | 269.5 | 262.2 |
| Deferred tax assets | 412.5 | 408.8 |
| Non-current other assets | 196.4 | 217.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total assets | $2577.1 | $2584.4 |
| **LIABILITIES AND STOCKHOLDERS' EQUITY** |  |  |
| Current Liabilities: |  |  |
| &nbsp;&nbsp;Accounts payable | $92.5 | $98.5 |
| &nbsp;&nbsp;Accrued liabilities | 169.5 | 172.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 262.0 | 270.9 |
| Long-term debt | 835.4 | 834.8 |
| Other long-term liabilities | 79.1 | 83.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 1176.5 | 1189.5 |
| Stockholders' Equity: |  |  |
| &nbsp;&nbsp;Preferred stock: |  |  |
| &nbsp;&nbsp;&nbsp;$0.001 par value; 10,000,000 shares authorized; no shares issued and outstanding |  |  |
| &nbsp;&nbsp;Common stock: |  |  |
| &nbsp;&nbsp;&nbsp;$0.001 par value; 120,000,000 shares authorized, 71,167,167 and 70,611,845 shares issued, <br>39,095,464 and 38,642,761 shares outstanding, at September 2025 and June 2025, respectively | 0.1 | 0.1 |
| &nbsp;&nbsp;Additional paid-in capital | 1245.3 | 1211.8 |
| &nbsp;&nbsp;&nbsp;Treasury stock: 32,071,703 and 31,969,084 common shares at September 2025 and June 2025, at cost | (1014.1) | (1006.9) |
| &nbsp;&nbsp;Retained earnings | 1169.3 | 1189.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' equity | 1400.6 | 1394.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and stockholders' equity | $2577.1 | $2584.4 |

---

*See accompanying notes to condensed consolidated financial statements (unaudited)* 

3

![synaptics-logo-full-color.jpg](syna-20250927_g1.jpg)

------

<u>[**Table of Contents**](#i5f09aefb843a4923977469c244fdfb01_7)</u>

**SYNAPTICS INCORPORATED AND SUBSIDIARIES** 

**CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS**

(in millions, except per share data)

(unaudited)

---

| | | |
|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** |
| | **September** | **September** |
| | **2025** | **2024** |
| Net revenue | $292.5 | $257.7 |
| Cost of revenue | 167.9 | 136.8 |
| Gross margin | 124.6 | 120.9 |
| Operating expenses: |  |  |
| &nbsp;&nbsp;Research and development | 94.4 | 81.3 |
| &nbsp;&nbsp;Selling, general, and administrative | 46.2 | 50.0 |
| &nbsp;&nbsp;Acquired intangibles amortization | 4.7 | 3.8 |
| &nbsp;&nbsp;Restructuring costs | 2.5 | 14.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 147.8 | 149.3 |
| Operating loss | (23.2) | (28.4) |
| Interest income (expense) and other, net | 0.5 | (5.9) |
| Loss before benefit from income taxes | (22.7) | (34.3) |
| Benefit from income taxes | (2.1) | (11.2) |
| Net loss | $(20.6) | $(23.1) |
| Net loss per share: |  |  |
| &nbsp;&nbsp;Basic | $(0.53) | $(0.58) |
| &nbsp;&nbsp;Diluted | $(0.53) | $(0.58) |
| Shares used in computing net loss per share: |  |  |
| &nbsp;&nbsp;Basic | 38.8 | 39.8 |
| &nbsp;&nbsp;Diluted | 38.8 | 39.8 |

---

*See accompanying notes to condensed consolidated financial statements (unaudited)*

4

![synaptics-logo-full-color.jpg](syna-20250927_g1.jpg)

------

<u>[**Table of Contents**](#i5f09aefb843a4923977469c244fdfb01_7)</u>

**SYNAPTICS INCORPORATED AND SUBSIDIARIES** 

**CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY**

(in millions, except share amounts)

(unaudited)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Common Stock** | **Common Stock** | | | | |
| | **Shares** | **Amount** |<br>**Additional Paid-In Capital**  |<br>**Treasury Stock**  |<br>**Retained Earnings**  |<br>**Total Stockholders'**<br>**Equity**  |
| Balance at June 2025 | 70611845 | $0.1 | $1211.8 | $(1006.9) | $1189.9 | $1394.9 |
| &nbsp;&nbsp;Net loss |  |  |  |  | (20.6) | (20.6) |
| &nbsp;&nbsp;Issuance of common stock for share-based award compensation plans | 555322 |  | 7.4 |  |  | 7.4 |
| &nbsp;&nbsp;Payroll taxes related to net share settlement of share-based awards |  |  | (10.6) |  |  | (10.6) |
| &nbsp;&nbsp;Common stock repurchased, inclusive of excise taxes |  |  |  | (7.2) |  | (7.2) |
| &nbsp;&nbsp;Share-based compensation |  |  | 36.7 |  |  | 36.7 |
| Balance at September 2025 | 71167167 | $0.1 | $1245.3 | $(1014.1) | $1169.3 | $1400.6 |

---

*See accompanying notes to condensed consolidated financial statements (unaudited)*

5

![synaptics-logo-full-color.jpg](syna-20250927_g1.jpg)

------

<u>[**Table of Contents**](#i5f09aefb843a4923977469c244fdfb01_7)</u>

**SYNAPTICS INCORPORATED AND SUBSIDIARIES** 

**CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY**

(in millions, except share amounts)

(unaudited)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Common Stock** | **Common Stock** | | | | |
| | **Shares** | **Amount** |<br>**Additional Paid-In Capital**  |<br>**Treasury Stock**  |<br>**Retained Earnings** |<br>**Total Stockholders'**<br>**Equity**  |
| Balance at June 2024 | 69683991 | $0.1 | $1107.0 | $(878.0) | $1237.7 | $1466.8 |
| &nbsp;&nbsp;Net loss |  |  |  |  | (23.1) | (23.1) |
| &nbsp;&nbsp;Issuance of common stock for share-based award compensation plans | 481580 |  | 7.7 |  |  | 7.7 |
| &nbsp;&nbsp;Payroll taxes related to net share settlement of share-based awards |  |  | (11.3) |  |  | (11.3) |
| &nbsp;&nbsp;Share-based compensation |  |  | 27.2 |  |  | 27.2 |
| Balance at September 2024 | 70165571 | $0.1 | $1130.6 | $(878.0) | $1214.6 | $1467.3 |

---

*See accompanying notes to condensed consolidated financial statements (unaudited)* 

6

![synaptics-logo-full-color.jpg](syna-20250927_g1.jpg)

------

<u>[**Table of Contents**](#i5f09aefb843a4923977469c244fdfb01_7)</u>

**SYNAPTICS INCORPORATED AND SUBSIDIARIES** 

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS** 

(in millions)

(unaudited)

---

| | | |
|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** |
| | **September** | **September** |
| | **2025** | **2024** |
| **Cash flows from operating activities** |  |  |
| &nbsp;&nbsp;Net loss | $(20.6) | $(23.1) |
| &nbsp;&nbsp;Adjustments to reconcile net loss to net cash provided by (used in) operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation costs | 36.7 | 27.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation | 7.5 | 7.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquired intangible assets amortization | 35.2 | 24.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred taxes | (4.2) | (15.0) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | 2.4 | 3.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities, net of acquisitions: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net | 10.8 | 6.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories, net | (2.9) | (4.6) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current and non-current assets | 3.9 | 1.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | (7.0) | (6.3) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued liabilities | (31.6) | (33.0) |
| Net cash provided by (used in) operating activities | 30.2 | (11.4) |
| **Cash flows from investing activities** |  |  |
| &nbsp;&nbsp;Proceeds from maturity of investments | 61.0 |  |
| &nbsp;&nbsp;Purchases of property and equipment | (12.2) | (9.1) |
| Net cash provided by (used in) investing activities | 48.8 | (9.1) |
| **Cash flows from financing activities** |  |  |
| &nbsp;&nbsp;Repurchases of common stock, excluding excise taxes | (7.2) |  |
| &nbsp;&nbsp;Proceeds from issuance of shares | 7.4 | 7.7 |
| &nbsp;&nbsp;Payroll taxes related to net share settlement of share-based awards | (10.6) | (11.3) |
| &nbsp;&nbsp;Repayment of debt |  | (1.5) |
| &nbsp;&nbsp;Other |  | 1.6 |
| Net cash used in financing activities | (10.4) | (3.5) |
| Effect of exchange rate changes on cash and cash equivalents | (0.2) | 0.7 |
| Net increase (decrease) in cash and cash equivalents | 68.4 | (23.3) |
| Cash and cash equivalents, beginning of period | 391.5 | 876.9 |
| Cash and cash equivalents, end of period | $459.9 | $853.6 |
| **Supplemental disclosure of non-cash transactions** |  |  |
| Receipt of intangible assets from advance payments | $42.5 | $— |

---

*See accompanying notes to condensed consolidated financial statements (unaudited)*

7

![synaptics-logo-full-color.jpg](syna-20250927_g1.jpg)

------

<u>[**Table of Contents**](#i5f09aefb843a4923977469c244fdfb01_7)</u>

**SYNAPTICS INCORPORATED AND SUBSIDIARIES** 

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS** 

(all tabular amounts in millions, except share and per share amounts)

(unaudited)

**1. Description of Business** 

We are a leading worldwide developer and fabless supplier of premium mixed signal semiconductor solutions designed to enable people to engage with connected devices and data, and create exceptional experiences throughout the home, at work, in the car and on the go. We provide our customers with sensing, processing and connecting solutions, which represent the three foundational elements of the Internet of Things ("IoT"). We supply connectivity, sensors and AI-enhanced processor solutions to original equipment manufacturers ("OEMs") that design IoT products and devices for automobiles, enterprise workspace devices, virtual reality, smartphones, tablets and notebook computers.

**2. Basis of Presentation and Principles of Consolidation**

The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission, or the SEC, and United States generally accepted accounting principles, or U.S. GAAP. Certain information or footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to SEC rules and regulations. In our opinion, the financial statements include all adjustments, which are of a normal and recurring nature and necessary for the fair presentation of the results of the interim periods presented. The results of operations for the interim periods are not necessarily indicative of the operating results for the full fiscal year or any future period. These financial statements should be read in conjunction with the audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended June 28, 2025.

The condensed consolidated financial statements include our financial statements and those of our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated upon consolidation. Certain reclassifications have been made to the amounts for prior years in order to conform to the current year's presentation.

Our fiscal year is the 52- or 53-week period ending on the last Saturday in June. Our fiscal 2026 and 2025 are the 52-week periods ending June 27, 2026 and June 28, 2025, respectively. The fiscal periods presented in this report are 13-week periods ended September 27, 2025 and September 28, 2024, respectively. For simplicity, the accompanying condensed consolidated financial statements have been shown as ending on calendar quarter end dates as of and for all periods presented, unless otherwise indicated.

*Use of Estimates*

The preparation of consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates including, but not limited to, those estimates related to revenue recognition, allowance for credit losses, cost of revenue, inventories, loss on purchase commitments, product warranty, accrued liabilities, share-based compensation costs, provision for income taxes, deferred tax assets and the associated valuation allowance, uncertain tax positions, goodwill, intangible assets, investments and loss contingencies. We base our estimates on historical experience, current period developments, applicable laws and regulations, and various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

*Significant Accounting Policies*

There have been no material changes to our significant accounting policies in Note 2 - Basis of Presentation and Significant Accounting Policies, of the Notes to Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended June 28, 2025.

*Accounting Pronouncements Recently Issued*

In December 2023, the FASB issued ASU No. 2023-09, "Income Taxes: Improvements to Income Tax Disclosures." This guidance requires consistent categories and greater disaggregation of information in the rate

8

![synaptics-logo-full-color.jpg](syna-20250927_g1.jpg)

------

<u>[**Table of Contents**](#i5f09aefb843a4923977469c244fdfb01_7)</u>

**SYNAPTICS INCORPORATED AND SUBSIDIARIES** 

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS** 

(all tabular amounts in millions, except share and per share amounts)

(unaudited)

reconciliation and disclosures of income taxes paid by jurisdiction. This amendment is effective for our fiscal year ending June 2026. We are currently assessing the impact of this guidance on our disclosures.

In November 2024, the FASB issued ASU No. 2024-03, "Income Statement - Reporting Comprehensive Income - Disaggregation of Income Statement Expenses." This guidance requires disclosures about specific types of expenses included in the expense captions presented on the face of the income statement as well as disclosures about selling expenses. This amendment is effective for our fiscal year ending June 2028 and our interim periods within the fiscal year ending June 2029. We are currently assessing the impact of this guidance on our disclosures.

**3. Supplemental Financial Statement Information**

Accounts receivable, net

---

| | | |
|:---|:---|:---|
| | September<br>2025 | June<br>2025 |
| Accounts receivable | $123.7 | $134.5 |
| Less: Allowance for credit losses | (4.2) | (4.2) |
|  | $119.5 | $130.3 |

---

*Inventories*

---

| | | |
|:---|:---|:---|
| | September<br>2025 | June<br>2025 |
| Raw materials and work-in-progress | $72.2 | $69.4 |
| Finished goods | 70.9 | 70.1 |
|  | $143.1 | $139.5 |

---

*Non-current other assets*

---

| | | |
|:---|:---|:---|
| | September | June |
| | 2025 | 2025 |
| Prepayment of intangible assets | $96.8 | $139.3 |
| Other | 57.2 | 32.6 |
| Right-of-use assets | 42.4 | 45.2 |
|  | $196.4 | $217.1 |

---

*Accrued liabilities*

---

| | | |
|:---|:---|:---|
| | September<br>2025 | June<br>2025 |
| Customer-related liabilities (1) | $68.6 | $67.2 |
| Accrued compensation and benefits | 27.4 | 58.9 |
| Other (2) | 73.5 | 46.3 |
|  | $169.5 | $172.4 |

---

(1) Primarily relates to customer rebates, but also includes deferred revenue, price discounts and stock rotation rights.

(2) As of September 2025, other accrued liabilities include a $25.0 million license fee payable to a third party. No such amount was payable at June 2025.

9

![synaptics-logo-full-color.jpg](syna-20250927_g1.jpg)

------

<u>[**Table of Contents**](#i5f09aefb843a4923977469c244fdfb01_7)</u>

**SYNAPTICS INCORPORATED AND SUBSIDIARIES** 

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS** 

(all tabular amounts in millions, except share and per share amounts)

(unaudited)

**4. Net Loss Per Share** 

The computation of basic and diluted net loss per share was as follows:

---

| | | |
|:---|:---|:---|
| | Three Months Ended | Three Months Ended |
| | September | September |
| | 2025 | 2024 |
| Numerator: |  |  |
| &nbsp;&nbsp;&nbsp;Net loss | $(20.6) | $(23.1) |
| Denominator: |  |  |
| &nbsp;&nbsp;&nbsp;Weighted-average shares - basic | 38.8 | 39.8 |
| &nbsp;&nbsp;&nbsp;Weighted-average shares - diluted | 38.8 | 39.8 |
| Net loss per share: |  |  |
| &nbsp;&nbsp;&nbsp;Basic | $(0.53) | $(0.58) |
| &nbsp;&nbsp;&nbsp;Diluted | $(0.53) | $(0.58) |

---

The following potentially dilutive securities were excluded from the computation of diluted net loss per share as their effect would have been antidilutive:

---

| | | |
|:---|:---|:---|
| | Three Months Ended | Three Months Ended |
| | September | September |
| | 2025 | 2024 |
| Share-based awards | 4.4 | 2.8 |
| Convertible senior notes | 4.5 |  |
| Total | 8.9 | 2.8 |

---

**5. Prepayment of Intangible Assets**

During the third quarter of fiscal 2025, we entered into definitive asset purchase agreements with Broadcom to acquire certain assets and obtain non-exclusive licenses relating to Broadcom's Wi-Fi Business in the IoT market for an aggregate consideration of $200.3 million. As of September 2025, we have not received six roadmap technology intangible assets, which are expected to be delivered at various dates through September 2027. Accordingly, the balance of $96.8 million, which represents the value of those technology intangible assets not yet received, is presented within non-current assets in our condensed consolidated balance sheets.

10

![synaptics-logo-full-color.jpg](syna-20250927_g1.jpg)

------

<u>[**Table of Contents**](#i5f09aefb843a4923977469c244fdfb01_7)</u>

**SYNAPTICS INCORPORATED AND SUBSIDIARIES** 

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS** 

(all tabular amounts in millions, except share and per share amounts)

(unaudited)

**6. Cash and Cash Equivalents and Short-Term Investments**

The following table summarizes our cash and cash equivalents by category at September 2025 and June 2025:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | September 2025 | September 2025 | September 2025 | June 2025 | June 2025 | June 2025 |
| | Amortized Cost | Gross unrealized loss | Fair Value | Amortized Cost | Gross unrealized loss | Fair Value |
| &nbsp;&nbsp;&nbsp;Cash | $357.4 | $— | $357.4 | $360.7 | $— | $360.7 |
| &nbsp;&nbsp;&nbsp;Cash equivalents: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Money market funds | 21.8 |  | 21.8 | 16.7 |  | 16.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Certificates of deposit | 80.7 |  | 80.7 | 14.1 |  | 14.1 |
| Total cash and cash equivalents | $459.9 | $— | $459.9 | $391.5 | $— | $391.5 |
| &nbsp;&nbsp;&nbsp;Short-term investments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Certificates of deposit | $— | $— | $— | $61.0 | $— | $61.0 |

---

**7. Fair Value Measurements**

We determine fair value based on the fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value assumes that the transaction to sell the asset or transfer the liability occurs in the principal or most advantageous market for the asset or liability and establishes that the fair value of an asset or liability shall be determined based on the assumptions that market participants would use in pricing the asset or liability. The classification of a financial asset or liability within the hierarchy is based upon the lowest level input that is significant to the fair value measurement. The fair value hierarchy prioritizes the inputs into three levels that may be used to measure fair value:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 1 – Valuation is based upon unadjusted quoted prices for identical assets or liabilities in active markets.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 2 – Valuation is based upon quoted prices for similar assets and liabilities in active markets, or other inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instruments.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 3 – Valuation is based upon other unobservable inputs that are significant to the fair value measurements.

Our Level 1 financial instruments are traded in active markets, and the fair value is based on quoted market prices for identical instruments. The fair value of our Level 2 fixed income securities is obtained from an independent pricing service, which may use quoted market prices for identical or comparable instruments or model driven valuations using observable market data or inputs corroborated by observable market data. Our marketable securities are held by custodians who obtain investment prices from a third-party pricing provider that incorporates standard inputs in various asset price models.

11

![synaptics-logo-full-color.jpg](syna-20250927_g1.jpg)

------

<u>[**Table of Contents**](#i5f09aefb843a4923977469c244fdfb01_7)</u>

**SYNAPTICS INCORPORATED AND SUBSIDIARIES** 

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS** 

(all tabular amounts in millions, except share and per share amounts)

(unaudited)

At September 2025 and June 2025, financial assets measured at fair value on a recurring basis are summarized below:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | September 2025 | September 2025 | September 2025 | June 2025 | June 2025 | June 2025 |
| | Level 1 | Level 2 | Total | Level 1 | Level 2 | Total |
| Cash equivalents: |  |  |  |  |  |  |
| &nbsp;&nbsp;Money market funds | $21.8 | $— | $21.8 | $16.7 | $— | $16.7 |
| &nbsp;&nbsp;Certificates of deposit |  | 80.7 | 80.7 |  | 14.1 | 14.1 |
| Total cash and cash equivalents | 21.8 | 80.7 | 102.5 | 16.7 | 14.1 | 30.8 |
| Short-term investments: |  |  |  |  |  |  |
| &nbsp;&nbsp;Certificates of deposit |  |  |  |  | 61.0 | 61.0 |
| Total assets measured at fair value | $21.8 | $80.7 | $102.5 | $16.7 | $75.1 | $91.8 |

---

We did not have any financial assets requiring Level 3 measurement in the periods presented.

*Financial Instruments Not Recorded at Fair Value on a Recurring Basis*

We report our financial instruments at fair value with the exception of the 2029 Notes and the 2031 Notes, or collectively with the 2029 Notes, the Notes, each as defined in Note 9. Debt. The estimated fair value of the Notes was determined based on the trading prices of the Notes as of the last day of trading for the periods presented. We use Level 2 measurement criteria to determine the fair value of our Notes as they are not actively traded in markets.

The carrying amounts and estimated fair values of the Notes are as follows for the periods presented:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | September 2025 | September 2025 | June 2025 | June 2025 |
| | Carrying Amount | Estimated Fair Value | Carrying Amount | Estimated Fair Value |
| 2029 Notes | $397.1 | $380.2 | $397.0 | $373.2 |
| 2031 Notes | 438.3 | 441.0 | 437.8 | 415.7 |
|  | $835.4 | $821.2 | $834.8 | $788.9 |

---

12

![synaptics-logo-full-color.jpg](syna-20250927_g1.jpg)

------

<u>[**Table of Contents**](#i5f09aefb843a4923977469c244fdfb01_7)</u>

**SYNAPTICS INCORPORATED AND SUBSIDIARIES** 

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS** 

(all tabular amounts in millions, except share and per share amounts)

(unaudited)

**8. Goodwill and Acquired Intangibles, Net**

*Goodwill*

The following table represents the change in our goodwill balance for the periods presented:

---

| | | |
|:---|:---|:---|
| | September | June |
| | 2025 | 2025 |
| Beginning balance | $872.3 | $816.4 |
| Acquisition activity |  | 55.9 |
| Ending balance | $872.3 | $872.3 |

---

*Acquired Intangibles, Net*

The following table summarizes the net carrying amounts, excluding fully amortized intangible assets:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | | September 2025 | September 2025 | September 2025 | June 2025 | June 2025 | June 2025 |
| |<br>Weighted Average<br>Life in Years | Gross Carrying<br>Value | Accumulated<br>Amortization | Net Carrying<br>Value | Gross Carrying<br>Value | Accumulated<br>Amortization | Net Carrying<br>Value |
| Audio and video technology | 5.6 | $231.9 | $(204.0) | $27.9 | $231.9 | $(198.4) | $33.5 |
| Customer relationships | 4.7 | 187.1 | (155.5) | 31.6 | 187.1 | (150.7) | 36.4 |
| Wireless connectivity technology | 4.6 | 314.4 | (154.3) | 160.1 | 271.9 | (139.6) | 132.3 |
| Video interface technology | 3.4 | 133.0 | (101.1) | 31.9 | 133.0 | (97.9) | 35.1 |
| Other | 2.4 | 41.9 | (30.7) | 11.2 | 52.1 | (34.0) | 18.1 |
| In-process research and development | Not applicable | 6.8 |  | 6.8 | 6.8 |  | 6.8 |
| Total intangible assets |  | $915.1 | $(645.6) | $269.5 | $882.8 | $(620.6) | $262.2 |

---

Fully amortized intangible assets are eliminated from both the gross and accumulated amortization amounts in the first quarter of each fiscal year.

In connection with a previous agreement with Broadcom entered into in July 2023 to acquire certain developed technologies, during the first quarter of fiscal 2026, we received and placed into service the last of the remaining technologies from Broadcom in the amount of $42.5 million with an estimated useful life of 6 years.

The following table presents details of amortization for the periods presented:

---

| | | |
|:---|:---|:---|
| | Three Months Ended | Three Months Ended |
| | September | September |
| | 2025 | 2024 |
| Cost of revenue | $30.5 | $20.8 |
| Acquired intangibles amortization | 4.7 | 3.8 |
| &nbsp;&nbsp;&nbsp;Total amortization of intangibles | $35.2 | $24.6 |

---

13

![synaptics-logo-full-color.jpg](syna-20250927_g1.jpg)

------

<u>[**Table of Contents**](#i5f09aefb843a4923977469c244fdfb01_7)</u>

**SYNAPTICS INCORPORATED AND SUBSIDIARIES** 

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS** 

(all tabular amounts in millions, except share and per share amounts)

(unaudited)

The following table presents the estimated future amortization expense of acquired amortizable intangible assets as of September 2025:

---

| | |
|:---|:---|
| Fiscal Year |  |
| Remainder of 2026 | $83.7 |
| 2027 | 69.3 |
| 2028 | 49.6 |
| 2029 | 26.5 |
| 2030 | 16.9 |
| Thereafter | 23.5 |
| &nbsp;&nbsp;&nbsp;Future amortization | $269.5 |

---

**9. Debt and Revolving Credit Facility** 

Our total debt outstanding consisted of the following:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | September 2025 | September 2025 | September 2025 | September 2025 | June 2025 | June 2025 |
| | | | | Net Carrying Amount | | Net Carrying Amount |
| | Stated Rate | Effective Rate |<br>Principal | Long-term |<br>Principal | Long-term |
| 2031 Notes | 0.75% | 1.19% | $450.0 | $450.0 | $450.0 | $450.0 |
| 2029 Notes | 4.00% | 4.17% | 400.0 | 400.0 | 400.0 | 400.0 |
| Total borrowings |  |  | 850.0 | 850.0 | 850.0 | 850.0 |
| Less: unamortized debt issuance costs |  |  |  | (14.6) |  | (15.2) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total debt |  |  | $850.0 | $835.4 | $850.0 | $834.8 |

---

**2031 Convertible Senior Notes**

On November 19, 2024 and November 26, 2024, we issued and sold $400.0 million and $50.0 million, respectively, in aggregate principal amount of 0.75% Convertible Senior Notes due 2031 ("2031 Notes") in a private placement. The 2031 Notes were issued pursuant to an indenture ("2031 Indenture"), dated November 19, 2024. The 2031 Notes are unsecured, bear interest at a fixed rate of 0.75% per year, payable semi-annually in arrears on June 1 and December 1 of each year, beginning on June 1, 2025, and mature on December 1, 2031, unless earlier converted, redeemed or repurchased by us.

The 2031 Notes are our senior, unsecured obligations and are (i) equal in right of payment with our existing and future senior unsecured indebtedness; (ii) senior in right of payment to our existing and future indebtedness that is expressly subordinated to the 2031 Notes; (iii) effectively subordinated to our existing and future secured indebtedness, to the extent of the value of the collateral securing that indebtedness; and (iv) structurally subordinated to all existing and future indebtedness and other liabilities.

The initial conversion rate of the 2031 Notes is 10.0308 shares of our common stock per $1,000 principal amount of 2031 Notes (which is equivalent to an initial conversion price of approximately $99.69 per share). The conversion rate is subject to adjustment upon the occurrence of certain events specified in the 2031 Indenture. In addition, upon the occurrence of a Make-Whole Fundamental Change or if we deliver a Redemption Notice, both as defined in the 2031 Indenture, we will, in certain circumstances, increase the conversion rate by a number of additional shares of common stock as described in the 2031 Indenture for a holder who elects to convert its 2031 Notes in connection with such Make-Whole Fundamental Change or to convert its 2031 Notes called (or deemed called as provided in the 2031 Indenture) for redemption in connection with such Redemption Notice, as the case may be.

14

![synaptics-logo-full-color.jpg](syna-20250927_g1.jpg)

------

<u>[**Table of Contents**](#i5f09aefb843a4923977469c244fdfb01_7)</u>

**SYNAPTICS INCORPORATED AND SUBSIDIARIES** 

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS** 

(all tabular amounts in millions, except share and per share amounts)

(unaudited)

At any time from, and including, September 2, 2031, the 2031 Notes are convertible at the option of the holders thereof only under the following circumstances: (1) during any calendar quarter commencing after the first calendar quarter ending on March 31, 2025, if the last reported sale price per share of our common stock exceeds 130% of the conversion price for at least 20 trading days (whether or not consecutive) during the 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter; (2) during the five consecutive business days after any ten consecutive trading day period (such ten consecutive trading day period, the "measurement period") in which the Trading Price per $1,000 principal amount of the 2031 Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price per share of our common stock on such trading day and the conversion rate on such trading day; (3) if we call such 2031 Notes for redemption; or (4) upon the occurrence of specified corporate events or distributions on our common stock (as defined in the 2031 Indenture). As of September 2025, none of the conditions allowing holders of the 2031 Notes to convert had been met. On or after September 2, 2031 until the close of business on the second scheduled trading day immediately preceding the maturity date of the 2031 Notes, holders of the 2031 Notes may convert all or a portion of their 2031 Notes, regardless of the foregoing conditions. Upon conversion, the 2031 Notes will be settled in cash, shares of our common stock based on the conversion rate (as defined in the 2031 Indenture) or any combination thereof, at our election.

The 2031 Notes are redeemable, at our option at any time, and from time to time, on or after December 6, 2028. We may redeem for cash all or any portion of the 2031 Notes (subject to the limitation described below), at our option, on or after December 6, 2028 and on or before the 40th scheduled trading day immediately before December 1, 2031 at a cash redemption price equal to the principal amount of the 2031 Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date, but only if (i) the notes are Freely Tradable (as defined in 2031 Indenture) as of the date we send the related redemption notice and all accrued and unpaid additional interest, if any, has been paid in full as of the most recent interest payment date occurring on or before the date we send such notice; and (ii) the last reported sale price per share of our common stock exceeds 130% of the conversion price on (1) each of at least 20 trading days, whether or not consecutive, during the 30 consecutive trading days ending on, and including, the trading day immediately before the date we send such redemption notice; and (2) the trading day immediately before the date we send such notice. However, we may not redeem less than all of the outstanding notes unless at least $100.0 million aggregate principal amount of notes are outstanding and not called for redemption as of the time we send, and after giving effect to, the related redemption notice. In addition, calling any note for redemption will constitute a Make-Whole Fundamental Change with respect to that note, in which case the conversion rate applicable to the conversion of that note will be increased in certain circumstances if it is converted after it is called for redemption. No sinking fund is provided for the 2031 Notes.

Upon the occurrence of a Fundamental Change (as defined in the 2031 Indenture) prior to the maturity date of the 2031 Notes, holders of the 2031 Notes may require us to repurchase their notes for a cash repurchase price equal to the principal amount of the 2031 Notes to be repurchased, plus any accrued and unpaid interest, if any, to, but excluding, the Fundamental Change Repurchase Date (as defined in the 2031 Indenture).

**2031 Capped Calls**

In connection with the issuance of the 2031 Notes, we entered into privately negotiated capped call transactions (each, a "2031 Capped Call" and collectively, the "2031 Capped Calls") with certain financial institutions. The 2031 Capped Calls have an initial strike price of $99.69, subject to certain adjustments, which corresponds to the initial conversion price of the 2031 Notes. The 2031 Capped Calls have an initial cap price of $150.48 per share, subject to certain adjustments. The 2031 Capped Calls are expected to partially offset the potential dilution to the Company's common stock upon any conversion of the 2031 Notes, with such offset subject to a cap based on the cap price. The 2031 Capped Calls cover, subject to anti-dilution adjustments, approximately 4.5 million shares of the Company's common stock. The 2031 Capped Calls are subject to adjustment upon the occurrence of specified extraordinary events affecting the Company, including merger events, tender offers and announcement events. For accounting purposes, each 2031 Capped Call is treated as a separate transaction from, and not part of, the terms of the 2031 Notes. As these transactions meet certain accounting criteria, the 2031 Capped Calls are recorded in stockholders' equity and are not accounted for as derivatives. The 2031 Capped Calls will not be remeasured as long as they continue to meet the conditions for equity classification.

Contractual interest expense and amortization of debt issuance costs on the 2031 Notes was $0.8 million and $0.5 million, respectively, during the three months ended September 2025.

15

![synaptics-logo-full-color.jpg](syna-20250927_g1.jpg)

------

<u>[**Table of Contents**](#i5f09aefb843a4923977469c244fdfb01_7)</u>

**SYNAPTICS INCORPORATED AND SUBSIDIARIES** 

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS** 

(all tabular amounts in millions, except share and per share amounts)

(unaudited)

**2029 Notes**

In March 2021, we issued $400.0 million aggregate principal amount of senior notes due June 15, 2029 ("2029 Notes"), which bear interest at a rate of 4.0% payable semi-annually on December 15 and June 15 of each year. The 2029 Notes are fully and unconditionally guaranteed, jointly and severally, on a senior unsecured basis by each of our current and future domestic restricted subsidiaries that guarantee our obligations under our senior secured credit facilities.

The indenture to the 2029 Notes (the "2029 Indenture") contains covenants that, among other things, limit our ability and the ability of our Restricted Subsidiaries (as defined in the 2029 Indenture) to (i) incur additional indebtedness and guarantee indebtedness; (ii) pay dividends or make other distributions or repurchase or redeem our company's or any parent's capital stock; (iii) prepay, redeem or repurchase certain indebtedness; (iv) issue certain preferred stock or similar equity securities; (v) make loans and investments; (vi) dispose of assets; (vii) incur liens; (viii) enter into transactions with affiliates; (ix) enter into agreements restricting its subsidiaries' ability to pay dividends; and (x) consolidate, merge or sell all, or substantially all, of its assets.

The 2029 Indenture contains customary events of default. An event of default under the 2029 Indenture will allow either the trustee or the holders of at least 25% in aggregate principal amount of the then outstanding 2029 Notes to accelerate, or in certain cases automatically cause the acceleration of, the maturity of the principal and accrued interest on all outstanding 2029 Notes.

We may redeem some or all of the 2029 Notes at a price of 101% of the principal amount in 2025 and at 100% of the principal amount in 2026 and thereafter.

Contractual interest expense and amortization of debt issuance costs on the 2029 Notes was as follows:

---

| | | |
|:---|:---|:---|
| | Three Months Ended | Three Months Ended |
| | September | September |
| | 2025 | 2024 |
| Interest expense | $4.0 | $4.0 |
| Amortization of debt issuance costs | 0.2 | 0.1 |
| Total interest expense | $4.2 | $4.1 |

---

**Term Loan Facility**

In December 2021, we entered into a first amendment and lender joinder agreement to our credit agreement, to, among other things, establish a new $600.0 million incremental term loan facility ("Term Loan Facility"). The Term Loan Facility was advanced by certain existing and new lenders under our credit agreement and was scheduled to mature on December 2, 2028. During the second quarter of fiscal 2025, we used a portion of the net proceeds from the 2031 Notes to repay the outstanding balance and accrued interest thereon.

For the three months ended September 2024, contractual interest expense and amortization of debt issuance costs on the Term Loan Facility was $11.7 million.

**Revolving Credit Facility**

We have $350.0 million available under a revolving credit agreement, as amended ("Revolving Credit Facility"), with a maturity date to be the earlier of (i) November 21, 2029 and (ii) ninety-one (91) days prior to any maturity of the 2029 Notes. Additionally, the Revolving Credit Facility provides a $25.0 million sublimit for letters of credit and a $25.0 million sublimit for swingline loans. As of September 2025, there was no balance outstanding under the Revolving Credit Facility.

The Revolving Credit Facility bears interest, at our election, at a Base Rate plus an Applicable Margin or Adjusted Term SOFR, as defined in the Revolving Credit Facility agreement. We are required to pay a commitment fee on any unused commitments which is determined on a leverage-based sliding scale ranging from 0.175% to 0.25% per annum. The unused commitment fees on the Revolving Credit Facility were $0.2 million and $0.1 million for the three months ended September 2025 and 2024, respectively.

16

![synaptics-logo-full-color.jpg](syna-20250927_g1.jpg)

------

<u>[**Table of Contents**](#i5f09aefb843a4923977469c244fdfb01_7)</u>

**SYNAPTICS INCORPORATED AND SUBSIDIARIES** 

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS** 

(all tabular amounts in millions, except share and per share amounts)

(unaudited)

The Revolving Credit Facility contains various restrictive covenants, including two financial covenants which limit the consolidated total net leverage ratio and the consolidated net interest coverage ratio. As of September 2025, we remain in compliance with the restrictive covenants.

**Maturities**

As of September 2025, principal maturities of our Notes were as follows:

---

| | | | |
|:---|:---|:---|:---|
| | 2029 Notes | 2031 Notes | Total |
| 2026 - 2028 | $— | $— | $— |
| 2029 | 400.0 |  | 400.0 |
| 2030 and thereafter |  | 450.0 | 450.0 |
|  | $400.0 | $450.0 | $850.0 |

---

**10. Leases**

As of September 2025 and June 2025, the components of leases are as follows:

---

| | | |
|:---|:---|:---|
| | September<br>2025 | June<br>2025 |
| Operating lease right-of-use assets | $42.4 | $45.2 |
| Operating lease liabilities | $11.3 | $12.3 |
| Operating lease liabilities, long-term | 33.5 | 35.8 |
| Total operating lease liabilities | $44.8 | $48.1 |

---

Supplemental cash flow information related to leases is as follows:

---

| | | |
|:---|:---|:---|
| | Three Months Ended | Three Months Ended |
| | September | September |
| | 2025 | 2024 |
| Cash paid for operating leases included in operating cash flows | $3.7 | $4.2 |
| Lease liabilities arising from obtaining right-of-use assets | $3.1 | $3.5 |

---

As of September 2025, the weighted average remaining lease term is 5.70 years, and the weighted average discount rate is 5.11%.

For the three months ended September 2025 and September 2024, we recorded operating lease expense of approximately $3.1 million and $3.2 million, respectively. Our short-term leases are immaterial, and we do not have finance leases.

17

![synaptics-logo-full-color.jpg](syna-20250927_g1.jpg)

------

<u>[**Table of Contents**](#i5f09aefb843a4923977469c244fdfb01_7)</u>

**SYNAPTICS INCORPORATED AND SUBSIDIARIES** 

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS** 

(all tabular amounts in millions, except share and per share amounts)

(unaudited)

Future minimum lease payments for the operating lease liabilities are as follows:

---

| | |
|:---|:---|
| Fiscal Year | Operating <br>Lease<br>Payments |
| Remainder of 2026 | $10.3 |
| 2027 | 9.8 |
| 2028 | 7.9 |
| 2029 | 7.0 |
| 2030 | 4.7 |
| Thereafter | 12.0 |
| Total future minimum operating lease payments | 51.7 |
| Less: interest | (6.9) |
| Total lease liabilities | $44.8 |

---

**11. Indemnifications and Contingencies**

*Commitments*

As of September 2025, we had commitments of $41.1 million for purchase obligations which include payments for the acquisition of inventories, other goods or services of either a fixed or minimum quantity and obligations for future payments related to software, technology and IP license agreements. Total future unconditional purchase commitments in future fiscal years were as follows:

---

| | |
|:---|:---|
| Remainder of 2026 | $27.2 |
| 2027 | 8.4 |
| 2028 | 5.5 |
| &nbsp;&nbsp;&nbsp;Total | $41.1 |

---

The amounts in the table above exclude gross unrecognized tax benefits related to uncertain tax positions of $42.3 million. As of September 2025, we were unable to make a reasonably reliable estimate of when cash settlement with a taxing authority may occur in connection with our gross unrecognized tax benefit.

*Indemnifications*

In connection with certain agreements, we are obligated to indemnify the counterparty against third party claims alleging infringement of certain intellectual property rights. We have in the past, and may in the future, receive notices from third parties that claim our products infringe their intellectual property rights. We cannot be certain that our technologies and products do not, and will not, infringe issued patents or other proprietary rights of third parties. Any infringement claims, with or without merit, could result in significant litigation costs and diversion of management and financial resources, including the payment of damages, which could have a material adverse effect on our business, financial condition and results of operations. We accrue for liabilities arising from indemnifications when it is both probable that we will incur the loss and we can reasonably estimate the amount of the loss or range of loss.

We have also entered into indemnification agreements with our officers and directors. Maximum potential future payments under these agreements cannot be estimated because these agreements generally do not have a maximum stated liability. However, historical costs related to these indemnification provisions have not been significant.

18

![synaptics-logo-full-color.jpg](syna-20250927_g1.jpg)

------

<u>[**Table of Contents**](#i5f09aefb843a4923977469c244fdfb01_7)</u>

**SYNAPTICS INCORPORATED AND SUBSIDIARIES** 

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS** 

(all tabular amounts in millions, except share and per share amounts)

(unaudited)

*Legal Proceedings*

From time to time, we are subject to various claims and legal proceedings, either asserted or unasserted, that arise in the ordinary course of business. We accrue for loss contingencies when it is both probable that we will incur the loss and we can reasonably estimate the amount of the loss or range of loss. While we currently believe that resolving claims against us, individually or in the aggregate, will not have a material adverse impact on our business, financial condition or results of operations, these matters are subject to inherent uncertainties and our view of these matters may change in the future.

**12. Common Stock Share-Based Compensation**

*Stock Repurchase Program*

We have a Board-approved stock repurchase program authorizing repurchases of up to $150.0 million of our common stock. This program does not have an expiration date; however, we will periodically review the authorization to assess its continued appropriateness in light of our capital allocation priorities and market conditions. The number of shares repurchased and the timing of repurchases depend on the level of our cash balances, general business and market conditions and other factors, including alternative investment opportunities.

During the three months ended September 2025, we repurchased $7.2 million of our common stock and $142.8 million remains available for future stock repurchases under the stock repurchase program.

*Share-Based Compensation*

Share-based compensation recognized in our condensed consolidated statements of operations was as follows:

---

| | | |
|:---|:---|:---|
| | Three Months Ended | Three Months Ended |
| | September | September |
| | 2025 | 2024 |
| Cost of revenue | $0.4 | $(2.7) |
| Research and development | 20.8 | 14.5 |
| Selling, general, and administrative | 15.5 | 15.4 |
| &nbsp;&nbsp;&nbsp;Total | $36.7 | $27.2 |

---

*Share-Based Compensation Plan Activity*

*Restricted Stock Units*

RSUs granted generally vest ratably over two to three years from the vesting commencement date. RSU activity was as follows:

---

| | | |
|:---|:---|:---|
| | RSU<br>Awards<br>Outstanding | Weighted-Average Grant Date Fair Value per Share |
| Balance as of June 2025 | 2981431 | $66.3 |
| &nbsp;&nbsp;&nbsp;Granted | 1524370 | $66.8 |
| &nbsp;&nbsp;&nbsp;Vested | (479511) | $84.0 |
| &nbsp;&nbsp;&nbsp;Forfeited | (75665) | $76.7 |
| Balance as of September 2025 | 3950625 | $64.1 |

---

The unrecognized share-based compensation cost of our outstanding RSUs was approximately $223.8 million as of September 2025, which will be recognized over a weighted average period of approximately 2.06 years.

19

![synaptics-logo-full-color.jpg](syna-20250927_g1.jpg)

------

<u>[**Table of Contents**](#i5f09aefb843a4923977469c244fdfb01_7)</u>

**SYNAPTICS INCORPORATED AND SUBSIDIARIES** 

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS** 

(all tabular amounts in millions, except share and per share amounts)

(unaudited)

*Market Stock Units*

An MSU is a promise to deliver shares of our common stock at a future date based on the achievement of market-based performance requirements in accordance with the terms of the MSU grant agreement.

MSU activity was as follows:

---

| | | |
|:---|:---|:---|
| | MSU<br>Awards<br>Outstanding | Weighted-Average Grant Date Fair Value per Share |
| Balance as of June 2025 | 104975 | $179.1 |
| &nbsp;&nbsp;&nbsp;Granted | 102750 | $103.1 |
| &nbsp;&nbsp;&nbsp;Delivered | (3545) | $187.0 |
| &nbsp;&nbsp;&nbsp;Forfeited | (42959) | $174.9 |
| Balance as of September 2025 | 161221 | $131.6 |

---

We value MSUs using the Monte Carlo simulation model on the date of grant and amortize the compensation expense over the three-year performance and service period on a ratable basis by tranche. The unrecognized share-based compensation cost of our outstanding MSUs was approximately $14.8 million as of September 2025, which will be recognized over a weighted average period of approximately 2.14 years.

*Performance Stock Units*

A PSU is a promise to deliver shares of our common stock at a future date based on the achievement of performance-based requirements in accordance with the terms of the PSU grant agreement.

PSU activity was as follows:

---

| | | |
|:---|:---|:---|
| | PSU<br>Awards<br>Outstanding | Weighted-Average Grant Date Fair Value per Share |
| Balance as of June 2025 | 191386 | $81.5 |
| &nbsp;&nbsp;&nbsp;Granted | 208327 | $73.9 |
| &nbsp;&nbsp;&nbsp;Delivered | (91181) | $76.4 |
| &nbsp;&nbsp;&nbsp;Forfeited | (23187) | $95.2 |
| Balance as of September 2025 | 285345 | $76.4 |

---

We value PSUs using the aggregate intrinsic value on the date of grant adjusted for estimated performance achievement during the performance period and amortize the compensation expense over the three-year service period on a ratable basis. The amount of stock-based compensation expense recognized in any period related to PSUs can vary based on the achievement or anticipated achievement of the performance conditions. If the performance conditions are not met, or not expected to be met, no compensation cost would be recognized on the underlying PSUs, and any previously recognized compensation expense related to those PSUs would be reversed. The unrecognized share-based compensation cost of our outstanding PSUs was approximately $13.6 million as of September 2025, which will be recognized over a weighted average period of approximately 1.39 years.

20

![synaptics-logo-full-color.jpg](syna-20250927_g1.jpg)

------

<u>[**Table of Contents**](#i5f09aefb843a4923977469c244fdfb01_7)</u>

**SYNAPTICS INCORPORATED AND SUBSIDIARIES** 

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS** 

(all tabular amounts in millions, except share and per share amounts)

(unaudited)

*Employee Stock Purchase Plan*

On October 28, 2025, our stockholders approved our amended and restated 2019 Employee Stock Purchase Plan. Shares purchased, weighted average purchase price, cash received, and the aggregate intrinsic value for employee stock purchase plan purchases during the three months ended September 2025, were as follows (in millions, except for shares purchased and weighted average price):

---

| | |
|:---|:---|
| Shares purchased | 139507 |
| Weighted average purchase price | $53.4 |
| Cash received | $7.4 |
| Aggregate intrinsic value | $2.4 |

---

**13. Income Taxes**

We account for income taxes under the asset and liability method. The provision for income taxes recorded in interim periods is based on our estimate of the annual effective tax rate applied to year-to-date income before provision for income taxes, adjusted for discrete items required to be recognized in the period in which they are incurred. In each quarter, we update our estimate of the annual effective tax rate, and if the estimated annual tax rate changes, we make a cumulative adjustment in that quarter. Our quarterly tax provision and our quarterly estimate of the annual effective tax rate can be subject to volatility due to several factors, including our ability to accurately forecast annual income before provision for income taxes in each of the tax jurisdictions in which we operate.

The benefit from income taxes of $2.1 million and $11.2 million for the three months ended September 2025 and September 2024, respectively, represented estimated federal, foreign, and state income taxes. The effective tax rate for the three months ended September 2025 diverged from the combined U.S. federal and state statutory tax rate primarily due to non-deductible share-based compensation and non-deductible officer compensation, partially offset by the benefit of research credits and foreign income taxed at lower rates. The effective tax rate for the three months ended September 2024 diverged from the combined U.S. federal and state statutory tax rate primarily due to a one-time deferred tax benefit of $7.7 million on inventory reserves transferred from foreign subsidiaries to the United States, foreign income taxed at lower rates, and research credits. This was partially offset by non-deductible officer compensation and non-deductible share-based compensation.

The total liability for gross unrecognized tax benefits related to uncertain tax positions decreased $2.3 million during the three months ended September 2025, to $42.3 million, and is included in other long-term liabilities on our condensed consolidated balance sheets. If recognized, the total gross unrecognized tax benefits would reduce the effective tax rate on income from continuing operations. Accrued interest and penalties related to unrecognized tax benefits as of September 2025 were $4.4 million; this balance increased by $0.2 million compared to June 2025. We classify interest and penalties as components of income tax expense. Any prospective adjustments to our unrecognized tax benefits will be recorded as an increase or decrease to income tax expense and cause a corresponding change to our effective tax rate. Accordingly, our effective tax rate could fluctuate materially from period to period.

Our major tax jurisdictions are the United States, Hong Kong SAR, Japan, Israel and the United Kingdom. From fiscal 2017 onward, we remain subject to examination by one or more of these jurisdictions.

**14. Revenue** 

The majority of our revenue is generated from product shipments to our customers. A summary of our product categories is as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Core IoT: Includes products for Wireless and Processor Solutions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Enterprise and Automotive: Includes products for PC Touch Pad, PC Fingerprint, Video Interface Solutions and Automotive Solutions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Mobile: Includes products for Touch and Display Solutions for Mobile phone applications.

21

![synaptics-logo-full-color.jpg](syna-20250927_g1.jpg)

------

<u>[**Table of Contents**](#i5f09aefb843a4923977469c244fdfb01_7)</u>

**SYNAPTICS INCORPORATED AND SUBSIDIARIES** 

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS** 

(all tabular amounts in millions, except share and per share amounts)

(unaudited)

*Disaggregation of revenue*

Net revenue by product category was as follows:

---

| | | |
|:---|:---|:---|
| | Three Months Ended | Three Months Ended |
| | September | September |
| | 2025 | 2024 |
| Enterprise and Automotive product applications | $147.7 | $147.6 |
| Core IoT product applications | 103.6 | 59.6 |
| Mobile product applications | 41.2 | 50.5 |
|  | $292.5 | $257.7 |

---

Net revenue by geographic region, based on the billing location of our customers, for the periods presented were as follows:

---

| | | |
|:---|:---|:---|
| | Three Months Ended | Three Months Ended |
| | September | September |
| | 2025 | 2024 |
| China/Hong Kong | $142.1 | $127.7 |
| Taiwan | 94.3 | 64.1 |
| Japan | 27.7 | 38.2 |
| Other | 15.1 | 10.6 |
| South Korea | 12.1 | 15.2 |
| United States | 1.2 | 1.9 |
|  | $292.5 | $257.7 |

---

Net revenue by customer whose revenue represented 10% or more of our total net revenue for the periods presented was as follows:

---

| | | |
|:---|:---|:---|
| | Three Months Ended | Three Months Ended |
| | September | September |
| | 2025 | 2024 |
| Customer A | 18% | 13% |
| Customer B | \* | 12% |
| Customer C | 15% | \* |

---

____________________________

\*Less than 10%

At September 2025 and June 2025, three customers comprised a total of 41% and 45% of our accounts receivable, respectively.

*Contract Liabilities*

Our contract liabilities are comprised of deferred revenue and primarily relate to our obligation to transfer goods, services or licenses of our IP to customers for which we have received consideration. Contract liabilities were $22.8 million and $16.2 million as of September 2025 and June 2025, respectively, and are presented as part of customer-related liabilities in accrued liabilities in the accompanying condensed consolidated balance sheets. See "Note 3. Supplemental Financial Statement Information." During the three months ended September 2025 and September 2024, we recognized $1.5 million and $12.6 million, respectively, in revenue related to contract liabilities outstanding as of the beginning of each such fiscal year.

22

![synaptics-logo-full-color.jpg](syna-20250927_g1.jpg)

------

<u>[**Table of Contents**](#i5f09aefb843a4923977469c244fdfb01_7)</u>

**SYNAPTICS INCORPORATED AND SUBSIDIARIES** 

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS** 

(all tabular amounts in millions, except share and per share amounts)

(unaudited)

**15. Segment and Other Information**

*Segment reporting*

We operate in one segment — the development, marketing and sale of semiconductor products used in electronic devices and products. This determination is based on the management approach, which designates internal information regularly available to the chief operating decision maker ("CODM") for making decisions and assessing performance as the source of determination of our reportable segment. Our CODM, the Chief Executive Officer, reviews financial information presented on a consolidated basis for the purpose of making operating decisions and assessing financial performance.

The CODM uses consolidated net income, as reported in our consolidated statements of operations, as the measure of profit or loss to allocate resources and assess performance. Financial forecasts and budget-to-actual results used by the CODM to assess performance and allocate resources, as well as those used for strategic decisions related to headcount and capital expenditures, are also reviewed on a consolidated basis. The CODM considers the impact of the significant segment expenses in the tables below when deciding whether to reinvest profits or pursue strategic mergers and acquisitions.

The measure of segment assets is reported on the consolidated balance sheet as total assets. The CODM does not review segment assets at a level other than that presented in the accompanying consolidated balance sheets.

The following table presents the calculation of segment net income as follows:

---

| | | |
|:---|:---|:---|
| | Three Months Ended | Three Months Ended |
| | September | September |
| | 2025 | 2024 |
| Revenue | $292.5 | $257.7 |
| Adjusted cost of revenue (1) | 137.0 | 118.7 |
| Adjusted operating expenses (2) | 104.0 | 95.9 |
| Stock-based compensation | 36.7 | 27.2 |
| Intangible asset amortization | 35.2 | 24.6 |
| Interest and other (income) expense, net | (1.2) | 5.3 |
| Income tax benefit | (2.1) | (11.2) |
| Other segment expenses (3) | 3.5 | 20.3 |
| Segment net loss | $(20.6) | $(23.1) |
| Consolidated net loss | $(20.6) | $(23.1) |

---

(1) Adjusted cost of revenue is cost of revenue adjusted for intangible asset amortization and stock-based compensation as follows:

---

| | | |
|:---|:---|:---|
| | Three Months Ended | Three Months Ended |
| | September | September |
| | 2025 | 2024 |
| Cost of revenue | $167.9 | $136.8 |
| Less: |  |  |
| Intangible asset amortization | 30.5 | 20.8 |
| Stock-based compensation | 0.4 | (2.7) |
| Adjusted cost of revenue | $137.0 | $118.7 |

---

23

![synaptics-logo-full-color.jpg](syna-20250927_g1.jpg)

------

<u>[**Table of Contents**](#i5f09aefb843a4923977469c244fdfb01_7)</u>

**SYNAPTICS INCORPORATED AND SUBSIDIARIES** 

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS** 

(all tabular amounts in millions, except share and per share amounts)

(unaudited)

(2) Adjusted operating expenses is operating expenses comprised of research and development and general and administrative expenses adjusted for stock-based compensation, intangible asset amortization, restructuring and impairment related charges as follows:

---

| | | |
|:---|:---|:---|
| | Three Months Ended | Three Months Ended |
| | September | September |
| | 2025 | 2024 |
| Operating expenses | $147.8 | $149.3 |
| Less: |  |  |
| Stock-based compensation | 36.3 | 29.9 |
| Intangible asset amortization | 4.7 | 3.8 |
| Restructuring costs | 2.5 | 14.2 |
| Other | 0.3 | 5.5 |
| Adjusted operating expenses | $104.0 | $95.9 |

---

(3) Other segment expenses primarily include restructuring charges, legal and vendor related charges and settlements, acquisition and integration related costs and amortization of debt issuance costs.

**16. Restructuring Activities**

We continuously evaluate our operations to reduce costs and increase profitability, increase operational efficiencies and gain synergies from our previous acquisitions and align our business in response to market conditions.

A summary of restructuring costs as presented in our condensed consolidated statements of operations is as follows:

---

| | | |
|:---|:---|:---|
| | Three Months Ended | Three Months Ended |
| | September | September |
| | 2025 | 2024 |
| Employee severance and related costs | $1.7 | $14.2 |
| &nbsp;&nbsp;Lease termination costs (1) | 0.8 |  |
|  | $2.5 | $14.2 |

---

The following table presents the beginning and ending restructuring liability balances for each restructuring action:

---

| | |
|:---|:---|
| | Fiscal 2026<br>Restructuring |
| Balance, June 2025 | $— |
| Charges | 1.7 |
| Payments | (1.3) |
| Balance, September 2025 | $0.4 |

---

(1) Lease termination costs of $0.8 million under the Fiscal 2025 Restructuring were recorded directly to the condensed consolidated statements of operations during the three months ended September 2025 are not included in the restructuring liability balance above.

*Fiscal 2026 Restructuring Plan*

A restructuring plan was initiated during the first quarter of fiscal 2026 ("Fiscal 2026 Restructuring Plan") to streamline and optimize resources and to reduce operating costs. Restructuring charges under this plan are

24

![synaptics-logo-full-color.jpg](syna-20250927_g1.jpg)

------

<u>[**Table of Contents**](#i5f09aefb843a4923977469c244fdfb01_7)</u> 

mainly comprised of severance and one-time termination benefits. We expect this restructuring action to be substantially completed by the end of the second quarter of fiscal 2026.

*Fiscal 2025 Restructuring Plan*

A restructuring plan was initiated during the first quarter of fiscal 2025 ("Fiscal 2025 Restructuring Plan") primarily intended to focus on key growth initiatives, reduce costs and align our business in response to market conditions. Restructuring charges were mainly comprised of severance and one-time termination benefits and lease termination costs. All restructuring actions under the Fiscal 2025 Restructuring Plan are complete as of the end of September 2025.

25

![synaptics-logo-full-color.jpg](syna-20250927_g1.jpg)

------

<u>[**Table of Contents**](#i5f09aefb843a4923977469c244fdfb01_7)</u> 

**ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS** 

**Forward-Looking Statements and Factors That May Affect Results**

This Quarterly Report on Form 10-Q for the quarter ended September 27, 2025 (this "Report") contains forward-looking statements that are subject to the safe harbors created under the Securities Act of 1933, as amended, or the Securities Act, and the Securities Exchange Act of 1934, as amended, or the Exchange Act. Forward-looking statements give our current expectations and projections relating to our financial condition, results of operations, plans, objectives, future performance and business, can be identified by the fact that they do not relate strictly to historical or current facts. Such forward-looking statements may include words such as "expect," "anticipate," "intend," "believe," "estimate," "plan," "target," "strategy," "continue," "may," "commit," "will," "should," variations of such words, or other words and terms of similar meaning. All forward-looking statements reflect our best judgment and are based on several factors relating to our operations and business environment, all of which are difficult to predict and many of which are beyond our control. Such factors include, but are not limited to the following: macroeconomic uncertainties in the U.S. and globally, including those caused by trade tensions and tariffs, resulting in supply chain disruptions, inflation, and market volatility, which may adversely affect our products and those of our customers and suppliers and result in reduced customer demand, component availability constraints, cost increases (both to us and our customers), supply chain disruption, and stock price volatility; risks related to our continued dependence on our solutions for the Core IoT and Enterprise and Automotive product applications market for a substantial portion of our revenue; risks related to the volatility of our net revenue from our solutions for Core IoT and Enterprise and Automotive product applications, including competition from new or established IoT and wireless service companies or from those with greater resources; our dependence on and/or loss of one or more large customers for a substantial portion of our revenue, and the loss of commitments from, contracts with, or a significant reduction in orders from, one or more of our major customers could have a material adverse effect on our revenue and operating results; our exposure to industry downturns and cyclicality in our target markets; the risk that our new product solutions for existing or new markets will not be successful; our ability to successfully execute on our strategy to develop integrated solutions including audio, touch and vision interfaces with embedded processing and wireless connectively for customer adoption; risks related to our expectations regarding technology and strategic investments and the anticipated timing or benefits thereof; historical and continued decreases in our average selling prices due to our product sales mix and decreased revenue from our mobile product applications; our ability to attract and retain key talent necessary to drive our strategic initiatives, including our Edge AI strategies, in a highly competitive industry; our ability to execute on our cost reduction initiatives and to achieve expected synergies and expense reductions; our ability to maintain and build relationships with our customers; our dependence on and/or interruption or loss of, a limited number of suppliers and subcontractors, including suppliers' manufacturing capacity constraints, the ability of these third parties to maintain satisfactory manufacturing yields and deliverable schedule; the risk that our indemnification obligations for third-party claims could result in substantial costs; risks and uncertainty related to regional instabilities and hostilities, economic volatility, and regulatory changes, any of which could disrupt our supply chain, elevate our costs and undermine the competitiveness of our offerings, requiring operational adjustments, such as reductions in force, or otherwise adversely affecting our financial condition and operating results; changes in export restrictions and laws affecting the Company's trade and investments; and the other risks as identified in the "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Business" sections of our Annual Report on Form 10-K for the fiscal year ended June 28, 2025, and other risks as identified from time to time in our SEC reports. Forward-looking statements are based on information available to us on the date hereof, and we do not have, and expressly disclaim, any obligation to publicly release any updates or any changes in our expectations, or any change in events, conditions, or circumstances on which any forward-looking statement is based, except as required by law. Our actual results and the timing of certain events could differ materially from the forward-looking statements. These forward-looking statements do not reflect the potential impact of any mergers, acquisitions, or other business combinations that have not been completed as of the date of this filing.

Statements made in this Report, unless the context otherwise requires, include the use of the terms "us," "we," "our," the "Company" and "Synaptics" to refer to Synaptics Incorporated and its consolidated subsidiaries.

**Overview**

We are a leading worldwide developer and fabless supplier of premium mixed signal semiconductor solutions. We develop solutions that integrate the audio, touch and vision interfaces with embedded processing capabilities that are paired with wireless connectivity. We believe our results to date reflect the combination of

26

![synaptics-logo-full-color.jpg](syna-20250927_g1.jpg)

------

<u>[**Table of Contents**](#i5f09aefb843a4923977469c244fdfb01_7)</u> 

our customer focus and the strength of our intellectual property and our engineering know-how, which allow us to develop or engineer products and solutions that meet the demanding design specifications of our OEMs.

Net revenue in the first quarter of fiscal 2026 was $292.5 million and was 13.5% higher than net revenue in the first quarter of fiscal 2025. This was primarily due to an increase in net revenue in our Core IoT product line, which increased 73.8% compared to the same period a year ago, primarily driven by an increase in units sold and an increase in average selling prices due to our product sales mix, inclusive of the contribution from the Broadcom transaction. Net revenue from our Enterprise and Automotive product line for the first quarter of fiscal 2026 compared to the same period a year ago remained flat and net revenue from our Mobile product category decreased by 18.4% primarily driven by a decrease in revenue from the licensing of certain of our IP.

Gross margin for the three months ended September 2025 and September 2024 was 42.6% and 46.9%, respectively. The decrease in gross margin was primarily due to a decrease in revenue from the licensing of certain of our IP and an increase in amortization of acquired intangible assets primarily from the developed technologies we acquired from Broadcom during fiscal 2025.

As of September 2025, our cash and cash equivalents of $459.9 million increased by $7.4 million compared to cash, cash equivalents and short-term investments of $452.5 million as of June 2025. During the three months ended September 2025, we generated $30.2 million of cash from operating activities, and we returned $7.2 million to stockholders through the repurchase of common stock under our stock repurchase program.

**Trends and Uncertainties**

*Macroeconomic Conditions and Regulations*

As a majority of our sales and manufacturing occurs outside of the U.S., we are exposed to and impacted by global macroeconomic factors, U.S. and foreign government policies and foreign exchange fluctuations. We continue to monitor changes in international trade policies, particularly increased tariffs and other barriers or restrictions between the United States and other countries, including China. Our current operations suggest limited tariff exposure given our current import and export practices. However, some of our customers and suppliers may be impacted by evolving tariff regimes depending on their own supply chain strategies and sourcing locations. We continue to monitor for any potential customer and supplier impacts, ranging from supply chain realignments to changes in end demand. While the broader implications of these activities remain uncertain, based on our current lead times and order activity, we are not seeing unusual activity that would suggest material pull-in or push-out of orders due to tariffs that would be likely to impact our near-term financial performance. We will continue to assess the short- and long-term effects of these international trade policies and restrictions on our financial and operational performance.

27

![synaptics-logo-full-color.jpg](syna-20250927_g1.jpg)

------

<u>[**Table of Contents**](#i5f09aefb843a4923977469c244fdfb01_7)</u> 

**Results of Operations** 

Certain of the data used in our condensed consolidated statements of operations for the periods indicated, together with comparative absolute and percentage changes in these amounts, were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** |
| | **September 2025** | **September 2025** | **September 2024** | **September 2024** |
| | **(in millions)** | **% of net revenue** | **(in millions)** | **% of net revenue** |
| Enterprise and Automotive product applications | $147.7 | 50.5% | $147.6 | 57.3% |
| Core IoT product applications | 103.6 | 35.4% | 59.6 | 23.1% |
| Mobile product applications | 41.2 | 14.1% | 50.5 | 19.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;Net revenue | 292.5 | 100.0% | 257.7 | 100.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross margin | 124.6 | 42.6% | 120.9 | 46.9% |
| Operating expenses: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Research and development | 94.4 | 32.3% | 81.3 | 31.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling, general and administrative | 46.2 | 15.8% | 50.0 | 19.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquired intangibles amortization | 4.7 | 1.6% | 3.8 | 1.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring costs | 2.5 | 0.9% | 14.2 | 5.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 147.8 | 50.6% | 149.3 | 57.9% |
| Operating loss | (23.2) | (8.0)% | (28.4) | (11.0%) |
| Interest income (expense) and other, net | 0.5 | 0.2% | (5.9) | (2.3%) |
| &nbsp;&nbsp;&nbsp;Loss before benefit from income taxes | (22.7) | (7.8)% | (34.3) | (13.3%) |
| &nbsp;&nbsp;&nbsp;Benefit from income taxes | (2.1) | (0.7)% | (11.2) | (4.3)% |
| &nbsp;&nbsp;&nbsp;Net loss | $(20.6) | (7.1%) | $(23.1) | (9.0%) |

---

*Net Revenue*

Net revenue was $292.5 million for the three months ended September 2025, compared with $257.7 million for the three months ended September 2024, an increase of $34.8 million, or 13.5%. Of this net revenue, $147.7 million, or 50.5%, was from Enterprise and Automotive product applications, $41.2 million, or 14.1%, was from Mobile product applications, and $103.6 million, or 35.4%, was from Core IoT product applications. Revenue increased in most of our product applications for the three months ended September 2025 compared with the three months ended September 2024. Net revenue from Core IoT product applications increased due to an increase in units sold (which increased 64.1%) and an increase in average selling prices (which increased 5.9%) due to our product sales mix compared to the same period a year ago, inclusive of the contribution from the Broadcom transaction. Net revenue from Enterprise and Automotive product applications slightly increased as a result of an increase in units sold (which increased 9.0%), partially offset by a decrease in average selling prices (which decreased 8.2%) due to our product sales mix compared to the same period a year ago. Net revenue from Mobile product applications decreased due to a decrease in average selling prices (which decreased 15.2%) and a decrease of $10.5 million in revenue from license of certain of our IP, partially offset by an increase in units sold (which increased 21.4%).

*Gross Margin* 

Gross margin as a percentage of net revenue was 42.6%, with gross margin of $124.6 million, for the three months ended September 2025, compared with 46.9%, with gross margin of $120.9 million, for the three months ended September 2024. The net 430 basis point decrease in gross margin as a percentage of net revenue for the three months ended September 2025 was primarily due to the increase in amortization of acquisition-related intangibles on the intangible assets we acquired from Broadcom during fiscal 2025 and a decrease in revenue from license of certain of our IP.

Because we sell our technology solutions in designs that are generally unique or specific to an OEM customer's application, gross margin varies on a product-by-product basis, making our cumulative gross margin a blend of our product specific designs. As a fabless manufacturer, our gross margin percentage is generally not materially

28

![synaptics-logo-full-color.jpg](syna-20250927_g1.jpg)

------

<u>[**Table of Contents**](#i5f09aefb843a4923977469c244fdfb01_7)</u> 

impacted by our shipment volume. Under most circumstances, revenue from license-based arrangements is accretive to our gross margin.

*Operating Expenses*

*Research and Development Expenses*. Research and development expenses increased $13.1 million to $94.4 million for the three months ended September 2025, compared with $81.3 million for the three months ended September 2024. The increase in research and development expenses was driven by a $6.3 million increase in stock-based compensation charges primarily related to awards issued to the workforce we acquired from Broadcom during fiscal 2025, a $2.8 million increase in project specific costs, and $1.8 million increase in wages and related costs related to an increase in headcount primarily driven by the employees we acquired from Broadcom during fiscal 2025.

*Selling, General, and Administrative Expenses*. Selling, general, and administrative expenses decreased $3.8 million to $46.2 million for the three months ended September 2025, compared with $50.0 million for the three months ended September 2024. The decrease in selling, general, and administrative expenses was primarily driven by a decrease of $4.5 million in professional service fees related to certain corporate projects that we incurred during the first quarter of fiscal 2025 with no corresponding corporate projects during the three months ended September 2025.

*Acquired Intangibles Amortization*. Amortization of acquisition-related intangibles increased $0.9 million, or 23.7% for the three months ended September 2025 compared to the same period a year ago, which is primarily related to the amortization on customer relationship and favorable supply contract intangible assets we acquired from Broadcom during fiscal 2025.

*Restructuring Costs*. Restructuring costs primarily reflect employee severance costs related to the restructuring of operations and to improve efficiencies in our operational activities. These headcount-related costs included personnel in research and development, and selling, general and administrative functions. See "Item 1. Condensed Consolidated Financial Statements (Unaudited) - Notes to Condensed Consolidated Financial Statements - Note 16. Restructuring Activities for additional information.

*Interest income (expense) and other, net*. Interest income/(expense) and other, net, include interest income and expense, amortization of debt issuance costs and other miscellaneous income or charges.

*Interest and other income.* Interest and other income includes interest income earned on our invested cash balances and other miscellaneous income. Interest and other income of $6.3 million decreased by $4.0 million for the three months ended September 2025, compared to the same period a year ago. The decrease was primarily driven by a decrease in interest income of $6.3 million due to the overall reduction in invested cash balances following the early repayment of the Term Loan Facility in November 2024 and the cash paid for the Broadcom acquisition in January 2025, partially offset by a $2.3 million increase in miscellaneous other income relating to a refund of amounts we paid previously to a third party.

*Interest expense*. Interest expense primarily includes interest expense on our debt, unused commitment fees on our revolving credit facility and amortization of debt issuance costs. Interest expense of $5.8 million for the three months ended September 2025, decreased by $10.4 million compared to the same period a year ago, which was primarily driven by the early repayment of the Term Loan Facility in November 2024. During the three months ended September 2024, the interest expense and amortization of debt issuance costs on the Term Loan facility was $11.7 million. The Term Loan Facility was repaid with the net proceeds received from the issuance of the 2031 Notes, which bear a significantly lower interest at a rate of 0.75%. See "Note 9. Debt" for additional information.

*(Benefit) Provision for Income Taxes*. We account for income taxes under the asset and liability method. The (benefit) provision for income taxes recorded in interim periods is based on our estimate of the annual effective tax rate applied to year-to-date (loss) income before (benefit) provision for income taxes, adjusted for discrete items required to be recognized in the period in which they are incurred. In each quarter, we update our estimate of the annual effective tax rate, and if the estimated annual tax rate changes, we make a cumulative adjustment in that quarter. Our quarterly tax (benefit) provision for income taxes and our quarterly estimate of the annual effective tax rate can be subject to volatility due to several factors, including our ability to accurately forecast annual (loss) income before (benefit) provision for income taxes in each of the tax jurisdictions in which we operate.

29

![synaptics-logo-full-color.jpg](syna-20250927_g1.jpg)

------

<u>[**Table of Contents**](#i5f09aefb843a4923977469c244fdfb01_7)</u> 

The Organization for Economic Co-operation and Development, or OECD, introduced Pillar Two Model Rules for a global minimum tax of 15% applicable to large multinational corporations. Many countries in which we have business operations, including the United Kingdom, Hong Kong, Switzerland, and Japan, have implemented certain aspects of Pillar Two. The OECD and the implementing countries are expected to keep issuing more guidance and refining their laws. Based on the latest legislation and our current estimate, Pillar Two had no impact on our effective tax rate or cash flows for the first three months of fiscal 2026. We will continue to evaluate the potential impact of these tax law changes in future reporting periods as further guidance becomes available.

On July 4, 2025, the One Big Beautiful Bill Act ("OBBBA") was signed into law. The legislation includes a permanent extension and modification of certain provisions under the 2017 Tax Cuts and Jobs Act ("TCJA"). Key provisions effective beginning in the first quarter of fiscal 2026 include immediate expensing of domestic research and experimentation (R&E) expenditures, 100% bonus depreciation for qualified property, and a modification to the business interest expense limitation, among others. These provisions were evaluated and reflected in our income tax provision for the three months ended September 2025 and did not have a material impact on our effective tax rate or cash flows. We will continue to monitor forthcoming Treasury and IRS guidance and assess potential implications for future reporting periods.

See "Item 1. Condensed Consolidated Financial Statements (Unaudited) - Notes to Condensed Consolidated Financial Statements - Note 13. Income Taxes for additional information.

**Liquidity and Capital Resources** 

Our cash and cash equivalents were $459.9 million and $391.5 million as of September 2025 and June 2025, respectively.

We consider almost all of the earnings of our foreign subsidiaries as not indefinitely invested overseas and have made appropriate provisions for income or withholding taxes that may result from a future repatriation of those earnings. As of September 2025, $363.4 million of cash and cash equivalents was held by our foreign subsidiaries. If these funds are needed for our operations in the United States, we would be able to repatriate substantially all of these funds without a material impact on our provision for income taxes.

*Cash Flows from Operating Activities*. Cash provided by operating activities during the three months ended September 2025 was $30.2 million compared with cash used by operating activities of $11.4 million during same period a year ago. For the three months ended September 2025, the primary operating activities were adjustments for non-cash charges of $77.6 million and net cash outflows of $26.8 million from changes in our operating assets and liabilities. The primary drivers of the change in operating assets and liabilities relate to a decrease of $31.6 million in accrued liabilities primarily related to the payment of our annual bonus, a decrease of $7.0 million in accounts payable due to the timing of payments made to our vendors, partially offset by a decrease in accounts receivable of $10.8 million primarily related to the timing of collections and billings.

During the three months ended September 2025 and September 2024, our days sales outstanding was 37 days and 47 days, respectively. Our annual inventory turns stayed consistent at four during the three months ended September 2025 and September 2024.

*Cash Flows from Investing Activities*. Cash provided by investing activities during the three months ended September 2025 was $48.8 million compared to cash used by investing activities of $9.1 million during the same period a year ago. The increase primarily relates to $61.0 million in proceeds from maturities of short-term investments, which we invested in investment classified as cash equivalents.

*Cash Flows from Financing Activities*. Cash used by financing activities for the three months ended September 2025 and September 2024 was $10.4 million and $3.5 million, respectively. The increase was primarily driven by $7.2 million in repurchases of our common stock with no share repurchase activity during the same period a year ago.

**Liquidity**

We have $350.0 million available under our revolving credit facility with a maturity date to be the earlier of November 2029 or three months prior to any maturity of our 2029 Notes. As of September 2025, there was no balance outstanding under this facility.

As of September 2025, our principal long-term debt obligations were $850.0 million.

30

![synaptics-logo-full-color.jpg](syna-20250927_g1.jpg)

------

<u>[**Table of Contents**](#i5f09aefb843a4923977469c244fdfb01_7)</u> 

As of September 2025, we had unconditional purchase commitments of $41.1 million, of which $27.2 million are for the remainder of fiscal 2026. We work continually with our suppliers and partners on the timing of payments and deliveries of purchase commitments, taking into account business conditions.

*Working Capital Needs*. We believe our existing cash and cash equivalents, anticipated cash flows from operating activities and available credit under our revolving credit facility, will be sufficient to meet our working capital and other cash requirements, and our debt service obligations for at least the next 12 months. Our future capital requirements will depend on many factors, including our revenue, the timing and extent of spending to support product development efforts, costs associated with restructuring activities net of projected savings from those activities, costs related to protecting our intellectual property, the expansion of sales and marketing activities, timing of introduction of new products and enhancements to existing products, costs to ensure access to adequate manufacturing, costs of maintaining sufficient space for our workforce, the continuing market acceptance of our product solutions, our common stock repurchase program, and the amount and timing of our investments in, or acquisitions of, other technologies or companies. Further equity or debt financing may not be available to us on acceptable terms. If sufficient funds are not available or are not available on acceptable terms, our ability to fund our future long-term working capital needs, take advantage of business opportunities or to respond to competitive pressures could be limited or severely constrained.

The undistributed earnings of our foreign subsidiaries are not currently required to meet our United States working capital and other cash requirements, but should we repatriate a portion of these earnings, we may be required to pay certain previously accrued state and foreign taxes, which would impact our cash flows.

**Critical Accounting Estimates** 

There have been no significant changes in our critical accounting estimates during the three months ended September 2025, compared with our critical accounting estimates disclosed in Management's Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K for the fiscal year ended June 28, 2025.

31

![synaptics-logo-full-color.jpg](syna-20250927_g1.jpg)

------

<u>[**Table of Contents**](#i5f09aefb843a4923977469c244fdfb01_7)</u> 

**ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK**

As of September 27, 2025, our market risk related to interest rates on our cash and cash equivalents, and foreign currency exchange risks has not changed materially from the risks disclosed in Item 7A of our Annual Report on Form 10-K for the fiscal year ended June 28, 2025.

**ITEM 4. CONTROLS AND PROCEDURES**

**Evaluation of Disclosure Controls and Procedures** 

Under the supervision and with the participation of our management, including our Principal Executive Officer and Principal Financial Officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act). Based on this evaluation, our Principal Executive Officer and Principal Financial Officer, as of September 27, 2025, concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) were effective to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC rules and forms, and that such information is accumulated and communicated to our management, including our Principal Executive Officer and Principal Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

**Changes in Internal Control over Financial Reporting**

We assessed, with the participation of our Principal Executive Officer and Principal Financial Officer, any change in our internal control over financial reporting as of the end of the fiscal quarter covered by this Report.

There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the period ended September 2025, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

32

![synaptics-logo-full-color.jpg](syna-20250927_g1.jpg)

------

<u>[**Table of Contents**](#i5f09aefb843a4923977469c244fdfb01_7)</u> 

**PART II—OTHER INFORMATION**

**ITEM 1. LEGAL PROCEEDINGS**

We are party to various litigation matters and claims arising from time to time in the ordinary course of business. While the results of such matters cannot be predicted with certainty, we believe that the final outcome of such matters will not have a material adverse effect on our business, financial condition, results of operations or cash flows.

**ITEM 1A. RISK FACTORS**

We refer you to the Company's risk factors set forth in Part I, Item 1A, "Risk Factors," of our Annual Report on Form 10-K for the fiscal year ended June 28, 2025 for material risks that may affect our business. There have been no material changes from the risk factors previously disclosed.

33

![synaptics-logo-full-color.jpg](syna-20250927_g1.jpg)

------

<u>[**Table of Contents**](#i5f09aefb843a4923977469c244fdfb01_7)</u> 

**ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS** 

**Issuer Purchases of Equity Securities** 

In August 2025, our Board of Directors authorized a stock repurchase program to repurchase up to $150.0 million of our common stock. This program does not have an expiration date; however, the Board will periodically review the authorization to assess its continued appropriateness in light of our capital allocation priorities and market conditions. Repurchases may be made in the open market or through privately negotiated transactions and are intended to comply with Rule 10b-18 under the Exchange Act.

The number of shares repurchased and the timing of repurchases depend on the level of our cash balances, general business and market conditions and other factors, including alternative investment opportunities.

During the three months ended September 2025, repurchases under our common stock repurchase program, excluding excise taxes, were as follows (in millions, except share and per share data):

---

| | | | | |
|:---|:---|:---|:---|:---|
| Period | Total Number of Shares Purchased | Average Price Paid Per Share | Total Number of Shares Purchased as Part of Publicly Announced Program | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program |
| June 29, 2025 - July 27, 2025 |  |  |  | $— |
| July 27, 2025 - August 23, 2025 |  |  |  | $— |
| August 24, 2025 - September 27, 2025 | 102619 | $70.58 | 102619 | $142.8 |
| Total | 102619 |  |  |  |

---

**ITEM 3. DEFAULTS UPON SENIOR SECURITIES**

None.

**ITEM 5. OTHER INFORMATION**

**Trading Arrangements**

During the fiscal quarter ended September 2025, none of our directors or officers (as defined in Rule 16a-1(f) of the Securities Exchange Act of 1934) adopted, terminated or modified a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K), except for the new adoptions as described below:

34

![synaptics-logo-full-color.jpg](syna-20250927_g1.jpg)

------

<u>[**Table of Contents**](#i5f09aefb843a4923977469c244fdfb01_7)</u> 

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | | | | Trading Arrangement | Trading Arrangement | | |
| Name | Title | Action | Date | Rule 10b5-1\* | Non-Rule 10b5-1\*\* | Total Shares to be Sold (1) | Expiration Date |
| Rahul Patel | President and Chief Executive Officer | Adopted | September 4, 2025 | X |  | Up to 48,569 | December 31, 2026 |
| Lisa Bodensteiner | Senior Vice President, Chief Legal Officer and secretary | Adopted | September 9, 2025 | X |  | Up to 25,364 | September 30, 2026 |
| Satish Ganesan | Senior Vice President and General Manager of Intelligent Sensing Division and Chief Strategy Officer | Adopted | September 11, 2025 | X |  | Up to 29,212 | September 30, 2026 |
| Vikram Gupta | Senior Vice President and General Manager of IoT Processors and Chief Product Officer | Adopted | September 12, 2025 | X |  | Up to 22,955 | September 30, 2026 |

---

\* Intended to satisfy the affirmative defense of Rule 10b5-1(c).

\*\* Not intended to satisfy the affirmative defense of Rule 10b5-1(c).

(1) The aggregate number of shares that will be available for sale under each plan is not yet determinable because the shares available will be net of shares sold to satisfy tax withholding obligations that arise in connection with the vesting and settlement of such equity awards, as well as performance stock units that will only vest upon achievement of applicable performance targets and may not vest at all. Additionally, certain provisions within the plan specify systematic periodic sales at pre-established price levels and at a certain percentage of the net shares that can be sold at the vesting date of the underlying equity award spanning over fiscal 26 and fiscal 27. For our Chief Executive Officer, generally 25% of net shares can be sold on the vesting date of the equity award spanning over fiscal 2026 and fiscal 2027. As such, for purposes of this disclosure, the shares included in this table reflect the aggregate maximum number of underlying shares the holders of the equity awards can sell without excluding (i) the amount of shares that will be sold to satisfy the tax withholding obligations and (ii) any limitations on the amount of net shares that can be sold on the vesting date of the equity award.

35

![synaptics-logo-full-color.jpg](syna-20250927_g1.jpg)

------

<u>[**Table of Contents**](#i5f09aefb843a4923977469c244fdfb01_7)</u> 

**ITEM 6. EXHIBITS**

---

| | |
|:---|:---|
| 3.1 | <u>[Synaptics Incorporated Amended and Restated Certificate of Incorporation (incorporated by reference to the registrant's Current Report on Form 8-K as filed with the SEC on October 26, 2023)](https://www.sec.gov/Archives/edgar/data/817720/000119312523264071/d511153dex31.htm)</u> |
| 3.2 | <u>[Fourth Amended and Restated Bylaws (incorporated by reference to the registrant's Current Report on Form 8-K as filed with the SEC on July 31, 2025)](https://www.sec.gov/Archives/edgar/data/817720/000081772025000062/syna-fourthamendedandresta.htm)</u> |
| 10.1\* | <u>[Synaptics Incorporated](https://www.sec.gov/Archives/edgar/data/0000817720/000081772025000092/equityplan.htm)[Amended and Restated 2019 Equity and Incentive Compensation Plan](https://www.sec.gov/Archives/edgar/data/0000817720/000081772025000092/equityplan.htm)[(incorporated by reference to the registrant's Current Report on F](https://www.sec.gov/Archives/edgar/data/0000817720/000081772025000092/equityplan.htm)[orm 8-K as filed with the SEC on October 30, 2025)](https://www.sec.gov/Archives/edgar/data/0000817720/000081772025000092/equityplan.htm)</u> |
| 10.2\* | <u>[Synaptics Incorporated Amended and Restated](https://www.sec.gov/Archives/edgar/data/0000817720/000081772025000092/espp.htm)[2019 Employee Stock Purchase Plan (incorporated by reference to the registrant's Current Report on](https://www.sec.gov/Archives/edgar/data/0000817720/000081772025000092/espp.htm)[Form 8-K as filed with the SEC on October 30, 2025)](https://www.sec.gov/Archives/edgar/data/0000817720/000081772025000092/espp.htm)</u> |
| 31.1 | <u>[Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a)](exhibit311-q126.htm)</u> |
| 31.2 | <u>[Certification of C](exhibit312-q126.htm)[hief Financial Officer](exhibit312-q126.htm)[pursuant to Rule 13a-14(a)/15d-14(a)](exhibit312-q126.htm)</u> |
| 32.1# | <u>[Section 1350 Certification of Chief Executive Officer](exhibit321-q126.htm)</u> |
| 32.2# | <u>[Section 1350](exhibit322-q126.htm)[Certification of Chief Financial Offic](exhibit322-q126.htm)[er](exhibit322-q126.htm)</u> |
| 101.INS Inline | XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document |
| 101.SCH Inline | Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents |
| 104 | Cover Page Interactive Data File – the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document |

---

______________________________________________________________________________________

\* Indicates a contract with management or compensatory plan or arrangement.

# This information is furnished and not filed for purposes of Sections 11 and 12 of the Securities Act of 1933 and Section 18 of the Securities Exchange Act of 1934.

36

![synaptics-logo-full-color.jpg](syna-20250927_g1.jpg)

------

<u>[**Table of Contents**](#i5f09aefb843a4923977469c244fdfb01_7)</u> 

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | **SYNAPTICS INCORPORATED** | **SYNAPTICS INCORPORATED** |
| Date: November 6, 2025 | By: | */s/ Rahul Patel* |
|  | Name: | Rahul Patel |
|  | Title: | President and Chief Executive Officer (Principal Executive Officer) |
| Date: November 6, 2025 | By: | */s/ Ken Rizvi* |
|  | Name: | Ken Rizvi |
|  | Title: | Senior Vice President and Chief Financial Officer<br>(Principal Financial Officer) |

---

37

![synaptics-logo-full-color.jpg](syna-20250927_g1.jpg)

## Exhibit 31.1

**Exhibit 31.1**

**Certification of Chief Executive Officer**

I, Rahul Patel, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Synaptics Incorporated;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: November 6, 2025 | |
| | */s/ Rahul Patel* |
| | Rahul Patel |
| | Chief Executive Officer |

---

## Exhibit 31.2

**Exhibit 31.2**

**Certification of Chief Financial Officer** 

I, Ken Rizvi, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Synaptics Incorporated;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: November 6, 2025 | |
| | */s/ Ken Rizvi* |
| | Ken Rizvi |
| | Chief Financial Officer  |

---

## Exhibit 32.1

**Exhibit 32.1**

**Section 1350 Certification of Chief Executive Officer**

&nbsp;&nbsp;&nbsp;&nbsp;In connection with the Quarterly Report on Form 10-Q of Synaptics Incorporated (the "Company") for the quarterly period ended September 27, 2025, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Rahul Patel, President and Chief Executive Officer of the Company, certify, to the best of my knowledge and belief, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) &nbsp;&nbsp;&nbsp;&nbsp;The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and

(2)&nbsp;&nbsp;&nbsp;&nbsp;The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| |
|:---|
| */s/ Rahul Patel* |
| Rahul Patel |
| Chief Executive Officer  |
| November 6, 2025 |

---

## Exhibit 32.2

**Exhibit 32.2**

**Section 1350 Certification of Chief Financial Officer** 

In connection with the Quarterly Report on Form 10-Q of Synaptics Incorporated (the "Company") for the quarterly period ended September 27, 2025, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Ken Rizvi, Chief Financial Officer of the Company, certify, to the best of my knowledge and belief, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)&nbsp;&nbsp;&nbsp;&nbsp;The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and

(2)&nbsp;&nbsp;&nbsp;&nbsp;The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| |
|:---|
| */s/ Ken Rizvi* |
| Ken Rizvi |
| Chief Financial Officer  |
| November 6, 2025 |

---

<br>